[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352647-105":59,"doc-detail-352647-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dance-based-avenues-to-advance-nonpharmacologic-treatment-of-chemotherapy-effects-daance-study-protocol-for-a-multi-center-randomized-controlled-trial","Dance-based avenues to advance nonpharmacologic treatment of chemotherapy effects (DAANCE) - study protocol for a multi-center, randomized controlled trial","","Breast cancer chemotherapy can produce chemotherapy-induced neuropathy (CIN), leading to sensory deficits such as pain, numbness, and tingling, alongside functional impairments in neuromotor control and motor-cognitive integration, reduced quality of life, and elevated fall risk. Pharmacologic approaches offer limited benefit and additional adverse side effects. In the absence of effective drug options, physical activity is a promising nonpharmacologic strategy. This protocol evaluates Adapted Argentine Tango as a patient-reported and clinically measurable intervention versus standard of care, targeting sensation and function in breast cancer survivors with CIN.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dance-based-avenues-to-advance-nonpharmacologic-treatment-of-chemotherapy-effects-daance-study-protocol-for-a-multi-center-randomized-controlled-trial/352647/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dance-based-avenues-to-advance-nonpharmacologic-treatment-of-chemotherapy-effects-daance-study-protocol-for-a-multi-center-randomized-controlled-trial/352647.png","ImageObject",300,407,{"name":92,"@type":93},"\tCallum ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main purpose of the DAANCE trial protocol?","Question",{"text":113,"@type":114},"To evaluate the effect of Adapted Argentine Tango as a physical-activity-based treatment for chemotherapy-induced neuropathy in breast cancer survivors, compared with standard of care.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are participants assigned in the study?",{"text":118,"@type":114},"Participants are randomly assigned in a 1:1 ratio to the Tango intervention arm or the standard-of-care active control arm, within a multi-center prospective randomized controlled design with optional one-way crossover.",{"name":120,"@type":111,"acceptedAnswer":121},"What outcomes are assessed during the intervention?",{"text":122,"@type":114},"Primary outcomes are patient-reported measures of sensation from baseline to after 4 weeks. Secondary outcomes include additional patient-reported outcomes (e.g., fatigue) and clinical measures of balance, gait, dual-task performance, and upper extremity function at 4 and 8 weeks, plus a 1-month follow-up.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352647,1790416869,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},137451211410,"https://ap-avatar.wpscdn.com/avatar/2000bb0a9246f588df?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786362646172706240","Luciani et al. Trials (2026) 27:246  \n[https://doi.org/10.1186/s13063-026-09486-w](https://doi.org/10.1186/s13063-026-09486-w)  \nTrials  \n STUDY PROTOCOL Open Access  \nDance-based avenues to advance  \nnonpharmacologic treatment of chemotherapy effects (DAANCE): study protocol  \nfor a multi-center, randomized controlled trial  \nBhillie D. Luciani 1, Aya Alwan1, Martha Carlson1, Gretchen McNally2, Madeleine E. Hackney3,4, Jewel E. Crasta5, Patrick Schnell6, Maryam B. Lustberg7 and Lise Worthen‑Chaudhari1*  \nAbstract  \nBackground Breast cancer (BC) is among the most common forms of cancer, particularly among women. Chemo‑ therapies that are most effective in treating BC are known to cause chemotherapy‑induced neuropathy (CIN), thus leaving survivors with sensory deficits including pain, numbness, and tingling in the extremities; functional deficits such as impaired neuromotor control and motor‑cognitive integration; reduced quality of life; and increased fall risk. Current pharmacologic treatments show limited efficacy and create additional unwanted side effects. In the absence of pharmacologic options, physical activity (PA) has emerged as a promising nonpharmacologic candidate for manag‑ ing CIN symptoms. The purpose of this trial is to evaluate the effect of Adapted Argentine Tango (Tango) as a potential PA‑based treatment for CIN. Toward this end, we will assess the intervention effect of Tango vs. the standard of care (SOC) on patient‑reported outcomes of sensation, clinically‑relevant measures of function, and potential mecha‑ nisms of action. We hypothesize that 4 weeks of Tango practice will improve sensation and function more than SOC among BC survivors with CIN and demonstrated balance dysfunction.  \nMethods In a multi‑center, prospective, randomized controlled clinical trial with optional one‑way crossover to inter‑ vention, participants are randomly assigned (1:1 ratio) to the Tango experimental or the SOC active control arms. The primary outcome is measured from baseline to after 4 weeks of intervention in patient‑reported outcomes (PROs) of sensation. Secondary outcomes include additional PROs, such as fatigue, and clinical measures of interest includ‑ ing dual‑task, balance, gait, and upper extremity function after 4 and 8 weeks of intervention and 1 month follow‑ ing intervention completion. Exploratory measures include postural control, gait stability, cognitive load, and blood‑ based biomarker concentrations. Linear mixed models will be used to model changes in measured outcomes. The primary estimand will be the difference in mean change in primary outcome from baseline to week 4 between treat‑ ment groups.  \nDiscussion The scientific premise of this study is that Tango, at a dose of 10–35 min performed no more than 2× per week, stands to improve CIN symptoms significantly more than the current standard of care by combining PA  \nwith auditory‑motor entrainment and social engagement. Our findings may lead to a safe non‑pharmacologic inter‑ vention that improves CIN‑related deficits.  \n*Correspondence:  \nLise Worthen‑Chaudhari  \nlise.worthen‑[chaudhari@osumc.edu](chaudhari@osumc.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Crea","cbCaiaTHPWJ711hX","https://ap.wps.com/l/cbCaiaTHPWJ711hX","pdf",2490509,21,"English","# Abstract\n# Methods\n# Discussion\n# Trial registration\n# Keywords\n# Introduction\n## Background and rationale","[{\"question\":\"What is the main purpose of the DAANCE trial protocol?\",\"answer\":\"To evaluate the effect of Adapted Argentine Tango as a physical-activity-based treatment for chemotherapy-induced neuropathy in breast cancer survivors, compared with standard of care.\"},{\"question\":\"How are participants assigned in the study?\",\"answer\":\"Participants are randomly assigned in a 1:1 ratio to the Tango intervention arm or the standard-of-care active control arm, within a multi-center prospective randomized controlled design with optional one-way crossover.\"},{\"question\":\"What outcomes are assessed during the intervention?\",\"answer\":\"Primary outcomes are patient-reported measures of sensation from baseline to after 4 weeks. Secondary outcomes include additional patient-reported outcomes (e.g., fatigue) and clinical measures of balance, gait, dual-task performance, and upper extremity function at 4 and 8 weeks, plus a 1-month follow-up.\"}]","Dance-based avenues to advance nonpharmacologic treatment of chemotherapy effects (DAANCE) - study protocol for a multi-center, randomized controlled trial | PDF",1790100606,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b070a2322f70bf669e03cee433f9f071.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a51aef15c3e4709587ba37345d6d2fb2.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/766f18bd81ab53a14777f432af4238b9.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6b057a084db743a0f7f771aeb4cdd2b.webp",980,1301]